XBI vs. KWEB
Compare and contrast key facts about SPDR S&P Biotech ETF (XBI) and KraneShares CSI China Internet ETF (KWEB).
XBI and KWEB are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006. KWEB is a passively managed fund by CICC that tracks the performance of the CSI Overseas China Internet. It was launched on Jul 31, 2013. Both XBI and KWEB are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: XBI or KWEB.
Performance
XBI vs. KWEB - Performance Comparison
Returns By Period
In the year-to-date period, XBI achieves a 5.76% return, which is significantly lower than KWEB's 13.70% return. Over the past 10 years, XBI has outperformed KWEB with an annualized return of 4.95%, while KWEB has yielded a comparatively lower -0.39% annualized return.
XBI
5.76%
-4.04%
5.72%
29.73%
1.44%
4.95%
KWEB
13.70%
-5.97%
2.57%
11.05%
-5.82%
-0.39%
Key characteristics
XBI | KWEB | |
---|---|---|
Sharpe Ratio | 1.18 | 0.31 |
Sortino Ratio | 1.73 | 0.74 |
Omega Ratio | 1.21 | 1.09 |
Calmar Ratio | 0.54 | 0.15 |
Martin Ratio | 3.96 | 0.92 |
Ulcer Index | 7.86% | 12.73% |
Daily Std Dev | 26.34% | 38.16% |
Max Drawdown | -63.89% | -80.92% |
Current Drawdown | -45.70% | -67.64% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XBI vs. KWEB - Expense Ratio Comparison
XBI has a 0.35% expense ratio, which is lower than KWEB's 0.76% expense ratio.
Correlation
The correlation between XBI and KWEB is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
XBI vs. KWEB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and KraneShares CSI China Internet ETF (KWEB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
XBI vs. KWEB - Dividend Comparison
XBI's dividend yield for the trailing twelve months is around 0.15%, less than KWEB's 1.50% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SPDR S&P Biotech ETF | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% | 0.17% |
KraneShares CSI China Internet ETF | 1.50% | 1.71% | 0.00% | 7.07% | 0.29% | 0.08% | 3.40% | 0.58% | 1.19% | 0.46% | 0.89% | 0.31% |
Drawdowns
XBI vs. KWEB - Drawdown Comparison
The maximum XBI drawdown since its inception was -63.89%, smaller than the maximum KWEB drawdown of -80.92%. Use the drawdown chart below to compare losses from any high point for XBI and KWEB. For additional features, visit the drawdowns tool.
Volatility
XBI vs. KWEB - Volatility Comparison
The current volatility for SPDR S&P Biotech ETF (XBI) is 8.40%, while KraneShares CSI China Internet ETF (KWEB) has a volatility of 11.77%. This indicates that XBI experiences smaller price fluctuations and is considered to be less risky than KWEB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.